%0 Journal Article %J Anal Chim Acta %D 2011 %T Impurity fingerprints for the identification of counterfeit medicines--a feasibility study. %A Sacré, Pierre-Yves %A Eric Deconinck %A Daszykowski, Michal %A Patricia Courselle %A Vancauwenberghe, Roy %A Chiap, Patrice %A Crommen, Jacques %A De Beer, Jacques O %K Algorithms %K Carbolines %K Chromatography, High Pressure Liquid %K Counterfeit Drugs %K Discriminant Analysis %K Drug Contamination %K Feasibility Studies %K Least-Squares Analysis %K Piperazines %K Principal Component Analysis %K Purines %K Sildenafil Citrate %K Spectrophotometry, Ultraviolet %K Sulfones %K Tablets %K Tadalafil %X

Most of the counterfeit medicines are manufactured in non good manufacturing practices (GMP) conditions by uncontrolled or street laboratories. Their chemical composition and purity of raw materials may, therefore, change in the course of time. The public health problem of counterfeit drugs is mostly due to this qualitative and quantitative variability in their formulation and impurity profiles. In this study, impurity profiles were treated like fingerprints representing the quality of the samples. A total of 73 samples of counterfeit and imitations of Viagra(®) and 44 samples of counterfeit and imitations of Cialis(®) were analysed on a HPLC-UV system. A clear distinction has been obtained between genuine and illegal tablets by the mean of a discriminant partial least squares analysis of the log transformed chromatograms. Following exploratory analysis of the data, two classification algorithms were applied and compared. In our study, the k-nearest neighbour classifier offered the best performance in terms of correct classification rate obtained with cross-validation and during external validation. For Viagra(®), both cross-validation and external validation sets returned a 100% correct classification rate. For Cialis(®) 92.3% and 100% correct classification rates were obtained from cross-validation and external validation, respectively.

%B Anal Chim Acta %V 701 %P 224-31 %8 2011 Sep 09 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21801892?dopt=Abstract %R 10.1016/j.aca.2011.05.041